The healthcare world is witnessing a remarkable shift in diabetes therapy with the introduction of GLP-1 patches. These patches offer a potentially more convenient alternative to subcutaneous administrations of GLP-1 receptor agonists, lessening the requirement of daily needle pricks. The technology administers the compound directly through the … Read More